I want to know more about the structure of the deal. What exactly has been licensed in/out and to whom (i.e., by how much have we cut potential profits globally by using Peptron's SR-formulation); for what cost (whether it be financial or otherwise); what are the limitations to each party during and post P3.
Some of these questions we already have answers to, or they won't be able to tell us, but it's important to ask anyway.
IXC Price at posting:
74.5¢ Sentiment: Buy Disclosure: Held
